Publications by authors named "Kathryn Collison"

Claim this Profile
S
Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator study.
Omar S Usmani, Fernando J Martinez, Hitesh Pandya, Matthew Camiolo, Artur Bednarczyk, Kathryn Collison

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential.
Magnus Aurivillius, Artur Bednarczyk, Marek Kokot, Jonathan Madriaga, Jie Mei, Kathryn Collison

Pulm Pharmacol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.
Thomas M Siler, Renu Jain, Kathryn Collison, Raj Sharma, Laura Sutton

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Study of a Patient Experience with an ELLIPTA Inhaler Electronic Medication Monitor and Associated Integrated System: A Prospective Observational Study Using the COPD Patient-Powered Research Network.
Barbara P Yawn, Gretchen M McCreary, John A Linnell, Cara B Pasquale, Elisha Malanga, Kathryn A Collison

Chronic Obstr Pulm Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
Martin Anderson, Kathryn Collison, M Bradley Drummond, Melanie Hamilton, Renu Jain

Int J Chron Obstruct Pulmon Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.
David J Collier, Pascal Wielders, Job van der Palen, Logan Heyes, Dawn Midwinter, Kathryn Collison

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of the correct use and ease-of use of the ELLIPTA DPI in children with asthma.
Philip Halverson, Joel Liem, Logan Heyes, Andy Preece, Philippe Bareille, Kathryn Collison

Pediatr Pulmonol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
Edward M Kerwin, Andrew Preece, Dimitra Brintziki, Kathryn A Collison, Raj Sharma

J Allergy Clin Immunol Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease.
Gregory J Feldman, Dmitry V Galkin, Pinal Patel, Kathryn A Collison, Raj Sharma

Chron Respir Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
Edward M Kerwin, Selwyn Spangenthal, Michael Zvarich, Valerie Millar, Renu Jain, Kathryn Collison

Chronic Obstr Pulm Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
Steven J Pascoe, Wei Wu, Kathryn A Collison, Linda M Nelsen, Keele E Wurst

Int J Chron Obstruct Pulmon Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference.
Kathryn A Collison, Pinal Patel, Andrew F Preece, Richard H Stanford, Raj K Sharma

COPD· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of umeclidinium on lung function and symptoms in patients with fixed airflow obstruction and reversibility to salbutamol: A randomised, 3-phase study.
Laurie Lee, Edward Kerwin, Kathryn Collison, Linda Nelsen, Wei Wu

Respir Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children.
Athena F Zuppa, Peter C Adamson, John T Mondick, Lauren A Davis, Deborah A Maka, Kathryn R Collison

J Clin Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoscintigraphic assessment of the regional drug absorption of the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240, in healthy volunteers.
Nancy E Martin, Kathryn R Collison, Louis L Martin, Sarah Tardif, Ian Wilding

J Clin Pharmacol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis